THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Icahn sold Genzyme stake when prices rose

Move settles talk about sale, breakup

Genzyme CEO Henri Termeer resisted pressure from Carl Icahn. Genzyme CEO Henri Termeer resisted pressure from Carl Icahn.
By Todd Wallack
Globe Staff / February 15, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Billionaire investor Carl Icahn, who has shaken up boardrooms at some of the world's best known corporations, has apparently decided to leave Genzyme Corp. alone for now. (Full article: 402 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass